Blood–brain barrier permeability considerations for CNS-targeted compound library design
A further refinement of the concept of drug-likeness is required for compound libraries intended for central nervous system (CNS) targets to account for the limitations imposed by blood–brain barrier permeability. This review describes criteria and processes that can be applied in the de novo design...
Gespeichert in:
Veröffentlicht in: | Current opinion in chemical biology 2008-06, Vol.12 (3), p.318-323 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 323 |
---|---|
container_issue | 3 |
container_start_page | 318 |
container_title | Current opinion in chemical biology |
container_volume | 12 |
creator | Hitchcock, Stephen A |
description | A further refinement of the concept of drug-likeness is required for compound libraries intended for central nervous system (CNS) targets to account for the limitations imposed by blood–brain barrier permeability. This review describes criteria and processes that can be applied in the
de novo design and assembly of libraries to increase the odds of compounds residing within CNS-accessible chemical space. A number of published examples where CNS activity and/or penetration characteristics have been a factor in library design are discussed. |
doi_str_mv | 10.1016/j.cbpa.2008.03.019 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69212429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1367593108000616</els_id><sourcerecordid>69212429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-be670f5ce37571e82d271f7818c4cd92860675c4dba25a20c42204e63d2cbcb43</originalsourceid><addsrcrecordid>eNqFkM1q3DAQx0Vp6G62fYEeik-92RnJH7Kgl3Zpk8CSHJJcehH6GActtuVI3kJufYe8YZ4kWnYht-Q0w8xv_jA_Qr5SKCjQ5mxbGD2pggG0BZQFUPGBLGnLRQ4VsI-pLxue16KkC3Ia4xYAGtbWn8iCtlWZ5nxJ_v7qvbfP_590UG7MtArBYcgmDAMq7Xo3P2bGj9FZDGp2qcs6H7L11U0-q3CPM9q0Hya_G23Wu5QSHjOL0d2Pn8lJp_qIX451Re7-_L5dX-Sb6_PL9c9NbmqAOdfYcOhqgyWvOcWWWcZpx1vamspYwdoGGl6bymrFasXAVIxBhU1pmdFGV-WKfD_kTsE_7DDOcnDRYN-rEf0uykYwyiom3gWpYIILWieQHUATfIwBOzkFN6TPJAW5Vy-3cq9e7tVLKGVSn46-HdN3ekD7enJ0nYAfBwCTjH_JsozG4WjQuoBmlta7t_JfAA0Ilo4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19297915</pqid></control><display><type>article</type><title>Blood–brain barrier permeability considerations for CNS-targeted compound library design</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hitchcock, Stephen A</creator><creatorcontrib>Hitchcock, Stephen A</creatorcontrib><description>A further refinement of the concept of drug-likeness is required for compound libraries intended for central nervous system (CNS) targets to account for the limitations imposed by blood–brain barrier permeability. This review describes criteria and processes that can be applied in the
de novo design and assembly of libraries to increase the odds of compounds residing within CNS-accessible chemical space. A number of published examples where CNS activity and/or penetration characteristics have been a factor in library design are discussed.</description><identifier>ISSN: 1367-5931</identifier><identifier>EISSN: 1879-0402</identifier><identifier>DOI: 10.1016/j.cbpa.2008.03.019</identifier><identifier>PMID: 18435937</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Blood-Brain Barrier - metabolism ; Central Nervous System - drug effects ; Central Nervous System - metabolism ; Drug Design ; Humans ; Permeability ; Small Molecule Libraries - metabolism ; Small Molecule Libraries - pharmacology</subject><ispartof>Current opinion in chemical biology, 2008-06, Vol.12 (3), p.318-323</ispartof><rights>2008 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-be670f5ce37571e82d271f7818c4cd92860675c4dba25a20c42204e63d2cbcb43</citedby><cites>FETCH-LOGICAL-c500t-be670f5ce37571e82d271f7818c4cd92860675c4dba25a20c42204e63d2cbcb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cbpa.2008.03.019$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18435937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hitchcock, Stephen A</creatorcontrib><title>Blood–brain barrier permeability considerations for CNS-targeted compound library design</title><title>Current opinion in chemical biology</title><addtitle>Curr Opin Chem Biol</addtitle><description>A further refinement of the concept of drug-likeness is required for compound libraries intended for central nervous system (CNS) targets to account for the limitations imposed by blood–brain barrier permeability. This review describes criteria and processes that can be applied in the
de novo design and assembly of libraries to increase the odds of compounds residing within CNS-accessible chemical space. A number of published examples where CNS activity and/or penetration characteristics have been a factor in library design are discussed.</description><subject>Animals</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Central Nervous System - drug effects</subject><subject>Central Nervous System - metabolism</subject><subject>Drug Design</subject><subject>Humans</subject><subject>Permeability</subject><subject>Small Molecule Libraries - metabolism</subject><subject>Small Molecule Libraries - pharmacology</subject><issn>1367-5931</issn><issn>1879-0402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1q3DAQx0Vp6G62fYEeik-92RnJH7Kgl3Zpk8CSHJJcehH6GActtuVI3kJufYe8YZ4kWnYht-Q0w8xv_jA_Qr5SKCjQ5mxbGD2pggG0BZQFUPGBLGnLRQ4VsI-pLxue16KkC3Ia4xYAGtbWn8iCtlWZ5nxJ_v7qvbfP_590UG7MtArBYcgmDAMq7Xo3P2bGj9FZDGp2qcs6H7L11U0-q3CPM9q0Hya_G23Wu5QSHjOL0d2Pn8lJp_qIX451Re7-_L5dX-Sb6_PL9c9NbmqAOdfYcOhqgyWvOcWWWcZpx1vamspYwdoGGl6bymrFasXAVIxBhU1pmdFGV-WKfD_kTsE_7DDOcnDRYN-rEf0uykYwyiom3gWpYIILWieQHUATfIwBOzkFN6TPJAW5Vy-3cq9e7tVLKGVSn46-HdN3ekD7enJ0nYAfBwCTjH_JsozG4WjQuoBmlta7t_JfAA0Ilo4</recordid><startdate>20080601</startdate><enddate>20080601</enddate><creator>Hitchcock, Stephen A</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20080601</creationdate><title>Blood–brain barrier permeability considerations for CNS-targeted compound library design</title><author>Hitchcock, Stephen A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-be670f5ce37571e82d271f7818c4cd92860675c4dba25a20c42204e63d2cbcb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Central Nervous System - drug effects</topic><topic>Central Nervous System - metabolism</topic><topic>Drug Design</topic><topic>Humans</topic><topic>Permeability</topic><topic>Small Molecule Libraries - metabolism</topic><topic>Small Molecule Libraries - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hitchcock, Stephen A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in chemical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hitchcock, Stephen A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood–brain barrier permeability considerations for CNS-targeted compound library design</atitle><jtitle>Current opinion in chemical biology</jtitle><addtitle>Curr Opin Chem Biol</addtitle><date>2008-06-01</date><risdate>2008</risdate><volume>12</volume><issue>3</issue><spage>318</spage><epage>323</epage><pages>318-323</pages><issn>1367-5931</issn><eissn>1879-0402</eissn><abstract>A further refinement of the concept of drug-likeness is required for compound libraries intended for central nervous system (CNS) targets to account for the limitations imposed by blood–brain barrier permeability. This review describes criteria and processes that can be applied in the
de novo design and assembly of libraries to increase the odds of compounds residing within CNS-accessible chemical space. A number of published examples where CNS activity and/or penetration characteristics have been a factor in library design are discussed.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>18435937</pmid><doi>10.1016/j.cbpa.2008.03.019</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1367-5931 |
ispartof | Current opinion in chemical biology, 2008-06, Vol.12 (3), p.318-323 |
issn | 1367-5931 1879-0402 |
language | eng |
recordid | cdi_proquest_miscellaneous_69212429 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Animals Blood-Brain Barrier - metabolism Central Nervous System - drug effects Central Nervous System - metabolism Drug Design Humans Permeability Small Molecule Libraries - metabolism Small Molecule Libraries - pharmacology |
title | Blood–brain barrier permeability considerations for CNS-targeted compound library design |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T08%3A45%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood%E2%80%93brain%20barrier%20permeability%20considerations%20for%20CNS-targeted%20compound%20library%20design&rft.jtitle=Current%20opinion%20in%20chemical%20biology&rft.au=Hitchcock,%20Stephen%20A&rft.date=2008-06-01&rft.volume=12&rft.issue=3&rft.spage=318&rft.epage=323&rft.pages=318-323&rft.issn=1367-5931&rft.eissn=1879-0402&rft_id=info:doi/10.1016/j.cbpa.2008.03.019&rft_dat=%3Cproquest_cross%3E69212429%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19297915&rft_id=info:pmid/18435937&rft_els_id=S1367593108000616&rfr_iscdi=true |